Sojournix

Sojournix is a biotechnology company developing medicines for women's health and neuroendocrine disorders. The Company is currently focused on the development of SJX-653, a novel, potent, and selective neurokinin-3 antagonist as a treatment for moderate to severe vasomotor symptoms due to menopause.